David Coghill

David Coghill

UNVERIFIED PROFILE

Are you David Coghill?   Register this Author

Register author
David Coghill

David Coghill

Publications by authors named "David Coghill"

Are you David Coghill?   Register this Author

99Publications

1887Reads

9Profile Views

Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples.

Authors:
Martine Hoogman Ryan Muetzel Joao P Guimaraes Elena Shumskaya Maarten Mennes Marcel P Zwiers Neda Jahanshad Gustavo Sudre Thomas Wolfers Eric A Earl Juan Carlos Soliva Vila Yolanda Vives-Gilabert Sabin Khadka Stephanie E Novotny Catharina A Hartman Dirk J Heslenfeld Lizanne J S Schweren Sara Ambrosino Bob Oranje Patrick de Zeeuw Tiffany M Chaim-Avancini Pedro G P Rosa Marcus V Zanetti Charles B Malpas Gregor Kohls Georg G von Polier Jochen Seitz Joseph Biederman Alysa E Doyle Anders M Dale Theo G M van Erp Jeffery N Epstein Terry L Jernigan Ramona Baur-Streubel Georg C Ziegler Kathrin C Zierhut Anouk Schrantee Marie F Høvik Astri J Lundervold Clare Kelly Hazel McCarthy Norbert Skokauskas Ruth L O'Gorman Tuura Anna Calvo Sara Lera-Miguel Rosa Nicolau Kaylita C Chantiluke Anastasia Christakou Alasdair Vance Mara Cercignani Matt C Gabel Philip Asherson Sarah Baumeister Daniel Brandeis Sarah Hohmann Ivanei E Bramati Fernanda Tovar-Moll Andreas J Fallgatter Bernd Kardatzki Lena Schwarz Anatoly Anikin Alexandr Baranov Tinatin Gogberashvili Dmitry Kapilushniy Anastasia Solovieva Hanan El Marroun Tonya White Georgii Karkashadze Leyla Namazova-Baranova Thomas Ethofer Paulo Mattos Tobias Banaschewski David Coghill Kerstin J Plessen Jonna Kuntsi Mitul A Mehta Yannis Paloyelis Neil A Harrison Mark A Bellgrove Tim J Silk Ana I Cubillo Katya Rubia Luisa Lazaro Silvia Brem Susanne Walitza Thomas Frodl Mariam Zentis Francisco X Castellanos Yuliya N Yoncheva Jan Haavik Liesbeth Reneman Annette Conzelmann Klaus-Peter Lesch Paul Pauli Andreas Reif Leanne Tamm Kerstin Konrad Eileen Oberwelland Weiss Geraldo F Busatto Mario R Louza Sarah Durston Pieter J Hoekstra Jaap Oosterlaan Michael C Stevens J Antoni Ramos-Quiroga Oscar Vilarroya Damien A Fair Joel T Nigg Paul M Thompson Jan K Buitelaar Stephen V Faraone Philip Shaw Henning Tiemeier Janita Bralten Barbara Franke

Am J Psychiatry 2019 Jul 24;176(7):531-542. Epub 2019 Apr 24.

The Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands (Hoogman, Guimaraes, Shumskaya, Wolfers, Bralten, Franke); the Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, the Netherlands (Hoogman, Shumskaya, Mennes, Wolfers, Buitelaar, Bralten, Franke); the Department of Child and Adolescent Psychiatry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (Muetzel, El Marroun, White, Tiemeier); the Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (Muetzel); the Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands (Guimaraes, Zwiers, Buitelaar); the Imaging Genetics Center, Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Marina del Rey, Calif. (Jahanshad, Thompson); National Human Genome Research Institute, Bethesda, Md. (Sudre, Shaw); the Department of Behavioral Neuroscience, Oregon Health and Science University, Portland (Earl, Fair, Nigg); the Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain (Soliva Vila, Ramos-Quiroga, Vilarroya); Instituto ITACA, Polytechnic University of Valencia, Valencia, Spain (Vives-Gilabert); the Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, Conn. (Khadka, Novotny, Stevens); University of Groningen, University Medical Center Groningen (UMCG), Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), Groningen, the Netherlands (Hartman, Schweren); Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam (Heslenfeld); the Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, the Netherlands (Hoekstra); NICHE Lab, Department of Psychiatry, UMC Utrecht Brain Center, Utrecht, the Netherlands (Ambrosino, Oranje, de Zeeuw, Durston); Laboratory of Psychiatric Neuroimaging (LIM-21), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil (Chaim-Avancini, Rosa, Zanetti, Busatto); the Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, São Paulo, Brazil (Chaim-Avancini, Rosa, Zanetti, Busatto); the Developmental Imaging Group, Murdoch Children's Research Institute, Melbourne, Australia (Malpas); the Clinical Outcomes Research Unit (CORe), Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia (Malpas); the Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia (Malpas); the Child Neuropsychology Section, University Hospital RWTH Aachen, Aachen, Germany (Kohls, Konrad; Child and Adolescent Psychiatry, University Hospital RWTH Aachen, Aachen, Germany (Polier, Seitz); Institute of Neuroscience and Medicine-Brain and Behavior (INM-7), Research Center Jülich, Jülich, Germany (Polier); the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Department of Psychiatry, Massachusetts General Hospital, Boston (Biederman); the Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Biederman, Doyle); the Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (Doyle); the Departments of Neurosciences, Radiology, and Psychiatry and the Center for Multimodal Imaging and Genetics, University of California San Diego (Dale); the Clinical and Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine (van Erp); the Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati (Epstein, Tamm); the Center for Human Development, University of California San Diego, San Diego (Jernigan); the Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany (Ziegler, Lesch); the Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam (Schrantee, Reneman); the Department of Clinical Medicine, University of Bergen, Bergen, Norway (Høvik); the Division of Psychiatry, Haukeland University Hospital, Bergen, Norway (Høvik, Haavik); the Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway (Lundervold); the K.G. Jebsen Center for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway (Lundervold, Haavik); the School of Psychology and the Department of Psychiatry, School of Medicine, and the Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland (Kelly); the Department of Child and Adolescent Psychiatry, NYU Langone Medical Center, New York (Kelly, Castellanos, Yoncheva); the Department of Psychiatry, Trinity College Dublin, Ireland (McCarthy, Skokauskas, Frodl); the Centre for Advanced Medical Imaging, St. James's Hospital, Dublin, Ireland (McCarthy); the Center for Child and Adolescent Mental Health, NTNU, Norway, Norwegian University of Science and Technology, Norway (Skokauskas); the Center for MR Research, University Children's Hospital, and the Zurich Center for Integrative Human Physiology, Zurich (O'Gorman Tuura); Magnetic Resonance Image Core Facility, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (Calvo, Lazaro); the Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clinic, Barcelona, Spain (Lera-Miguel, Nicolau, Lazaro); the Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Chantiluke, Christakou, Cubillo, Rubia); the School of Psychology and Clinical Language Sciences, Centre for Integrative Neuroscience and Neurodynamics, University of Reading, Reading, U.K. (Christakou); the Department of Paediatrics, University of Melbourne, Australia (Vance, Coghill, Silk); the Department of Neuroscience, Brighton and Sussex Medical School, Falmer, Brighton, U.K. (Cercignani, Gabel, Harrison); the Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Asherson, Kuntsi); the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany (Baumeister, Brandeis, Hohmann, Banaschewski); the Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich (Brandeis, Brem, Walitza); the Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich (Brandeis, Brem, Walitza); the D'Or Institute for Research and Education, Rio de Janeiro (Bramati, Tovar-Moll, Mattos); the Morphological Sciences Program, Federal University of Rio de Janeiro, Rio de Janeiro (Tovar-Moll); the Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany (Fallgatter, Schwarz, Ethofer); LEAD Graduate School, University of Tübingen, Germany (Fallgatter); the Department of Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany (Kardatzki, Ethofer); the National Medical Research Center for Children's Health, Department of Magnetic Resonance Imaging and Densitometry, Moscow (Anikin); the National Medical Research Center for Children's Health, Moscow (Baranov, Solovieva); Russian National Research Medical University, Ministry of Health and Social Development of the Russian Federation, Central Clinical Hospital MSHE, Moscow (Namazova-Baranova); the National Medical Research Center for Children's Health, Laboratory of Neurology and Cognitive Health, Moscow (Gogberashvili, Karkashadze); the National Medical Research Center for Children's Health, Department of Information Technologies, Moscow (Kapilushniy); the Department of Pediatrics, Erasmus MC-Sophia, Rotterdam, the Netherlands (El Marroun); the Department of Psychology, Education, and Child Studies, Erasmus University Rotterdam, Rotterdam, the Netherlands (El Marroun); the Department of Radiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (White); Federal University of Rio de Janeiro, Rio de Janeiro (Mattos); the Department of Psychiatry, University of Melbourne, Melbourne, Australia (Coghill); the Murdoch Children's Research Institute, Melbourne, Australia (Coghill, Silk); the Division of Neuroscience, University of Dundee, Dundee, U.K. (Coghill); the Child and Adolescent Mental Health Center, Capital Region Copenhagen (Plessen); the Division of Child and Adolescent Psychiatry, Department of Psychiatry, University Hospital Lausanne, Switzerland (Plessen); the Department of Neuroimaging, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Mehta, Paloyelis); Sussex Partnership NHS Foundation Trust, Swandean, East Sussex, U.K. (Harrison); the Monash Institute for Cognitive and Clinical Neurosciences (MICCN) and the School of Psychological Sciences, Monash University, Melbourne, Australia (Bellgrove); Deakin University, School of Psychology, Geelong, Australia (Silk); the Department of Medicine, University of Barcelona, Barcelona, Spain (Lazaro); the Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Germany (Frodl); the German Center for Neurodegenerative Diseases (DZNE), Germany (Frodl); Bezirksklinikum Regensburg, Germany (Zentis); the Nathan Kline Institute for Psychiatric Research, Orangeburg, N.Y. (Castellanos); the Brain Imaging Center, Amsterdam University Medical Centers, Amsterdam (Reneman); the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Tübingen, Germany (Conzelmann); the Department of Psychology, Biological Psychology, Clinical Psychology, and Psychotherapy, University of Würzburg, Würzburg, Germany (Conzelmann, Pauli, Baur-Streubel, Zierhut); the Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow (Lesch); the Department of Neuroscience, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, the Netherlands (Lesch); the Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany (Reif); JARA Institute Molecular Neuroscience and Neuroimaging (INM-11), Institute for Neuroscience and Medicine, Research Center Jülich, Germany (Konrad); Translational Neuroscience, Child and Adolescent Psychiatry, University Hospital RWTH Aachen, Aachen, Germany (Oberwelland Weiss); Cognitive Neuroscience (INM-3), Institute for Neuroscience and Medicine, Research Center Jülich, Germany (Oberwelland Weiss); the Department of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil (Busatto, Louza); the Clinical Neuropsychology Section, Vrije Universiteit Amsterdam, Amsterdam (Oosterlaan); Emma Children's Hospital Amsterdam Medical Center, Amsterdam (Oosterlaan); the Department of Pediatrics, VU Medical Center, Amsterdam (Oosterlaan); the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn. (Stevens); the Department of Psychiatry, Vall d'Hebron University Hospital, Barcelona, Spain (Ramos-Quiroga); Biomedical Network Research Center on Mental Health (CIBERSAM), Barcelona, Spain (Lazaro, Ramos-Quiroga); Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain (Vilarroya); the Department of Psychiatry, Oregon Health and Science University, Portland (Fair, Nigg); Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands (Buitelaar); Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York (Faraone); NIHM, Bethesda, Md. (Shaw); the Department of Social and Behavioral Science, Harvard T.H. Chan School of Public Health, Boston (Tiemeier).

View Article

Download full-text PDF

Source
http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.18
Publisher Site
http://dx.doi.org/10.1176/appi.ajp.2019.18091033DOI Listing
July 2019

Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials.

Lancet Psychiatry 2019 Jun;6(6):528-537

Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Murdoch Children's Research Institute, Melbourne, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(19)30096-3DOI Listing
June 2019

Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long-Term?

J Am Acad Child Adolesc Psychiatry 2019 Jun 26. Epub 2019 Jun 26.

Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; and the Royal Children's Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaac.2019.04.029DOI Listing
June 2019

Treatment strategies for ADHD: an evidence-based guide to select optimal treatment.

Mol Psychiatry 2019 03 28;24(3):390-408. Epub 2018 Jun 28.

Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41380-018-0116-3DOI Listing
March 2019

Reply to Leon .

Evid Based Ment Health 2019 02;22(1):e2

Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebmental-2019-300081DOI Listing
February 2019

Mental health difficulties across childhood and mental health service use: findings from a longitudinal population-based study.

Br J Psychiatry 2019 Feb 27:1-6. Epub 2019 Feb 27.

Professor of Child and Adolescent Psychiatry,Faculty of Health and Medical Sciences, University of Adelaide,Australia.

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S000712501
Publisher Site
http://dx.doi.org/10.1192/bjp.2019.32DOI Listing
February 2019

Can depression be prevented in children and adolescents?

J Paediatr Child Health 2018 Dec 30;54(12):1386-1388. Epub 2018 Oct 30.

Royal Children's Hospital, Melbourne, Victoria Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpc.14267DOI Listing
December 2018

Twenty years of research on attention-deficit/hyperactivity disorder (ADHD): looking back, looking forward.

Evid Based Ment Health 2018 Nov 9;21(4):173-176. Epub 2018 Oct 9.

Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebmental-2018-300050DOI Listing
November 2018

Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply.

Lancet Psychiatry 2018 Nov 26;5(11):871-873. Epub 2018 Oct 26.

Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK; Centre for Innovation in Mental Health, Academic Unit of Psychology, and Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK; Solent NHS Trust, Southampton, UK; New York University Child Study Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(18)30396-1DOI Listing
November 2018

Standardised assessment of functioning in ADHD: consensus on the ICF Core Sets for ADHD.

Eur Child Adolesc Psychiatry 2018 Oct 12;27(10):1261-1281. Epub 2018 Feb 12.

ICF Research Branch a cooperation partner within the WHO Collaborating Center for the Family of International Classifications in Germany (at DIMDI), Nottwil, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00787-018-1119-y
Publisher Site
http://dx.doi.org/10.1007/s00787-018-1119-yDOI Listing
October 2018

An international clinical study of ability and disability in ADHD using the WHO-ICF framework.

Eur Child Adolesc Psychiatry 2018 Oct 17;27(10):1305-1319. Epub 2018 Feb 17.

Division of Neuropsychiatry, Department of Women's and Children's Health, Center of Neurodevelopmental Disorders (KIND), CAP Research Center, Karolinska Institutet, Gävlegatan 22, 11330, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-018-1124-1DOI Listing
October 2018

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Lancet Psychiatry 2018 10 13;5(10):824-835. Epub 2018 Sep 13.

Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Research Department of Policy and Practice, University College London School of Pharmacy, London, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22150366183029
Publisher Site
http://dx.doi.org/10.1016/S2215-0366(18)30293-1DOI Listing
October 2018

The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication?

Neurosci Biobehav Rev 2018 08 27;91:218-238. Epub 2017 Jan 27.

Child & Adolescent Neuropsychiatric Unit, Department of Biomedical Science, University of Cagliari & "A. Cao" Microcitemico Paediatric Hospital, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neubiorev.2017.01.024DOI Listing
August 2018

Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis.

Neurosci Biobehav Rev 2018 03 13;86:1-11. Epub 2017 Dec 13.

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neubiorev.2017.12.007DOI Listing
March 2018

ADHD in children and young people: prevalence, care pathways, and service provision.

Lancet Psychiatry 2018 02 9;5(2):175-186. Epub 2017 Oct 9.

Division of Neuroscience, School of Medicine, University of Dundee, Dundee, UK; Department of Paediatrics and Department of Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22150366173016
Publisher Site
http://dx.doi.org/10.1016/S2215-0366(17)30167-0DOI Listing
February 2018

Barriers to medication entitlements after diagnosis of ADHD - Authors' reply.

Lancet Psychiatry 2018 01;5(1):19-20

Division of Neuroscience, School of Medicine, University of Dundee, Dundee, UK; Department of Paediatrics and Department of Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(17)30487-XDOI Listing
January 2018

Developing the Symptoms and Functional Impairment Rating Scale: A Multi-Dimensional ADHD Scale.

Psychiatry Investig 2018 Jan 16;15(1):13-23. Epub 2018 Jan 16.

Division of Neuroscience, Medical Research Institute, University of Dundee, Ninewells Hospital, Dundee, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4306/pi.2018.15.1.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795025PMC
January 2018

Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder.

Eur Child Adolesc Psychiatry 2017 Nov 20;26(11):1283-1307. Epub 2017 Apr 20.

Child and Adolescent Psychiatry Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00787-017-0986-y
Publisher Site
http://dx.doi.org/10.1007/s00787-017-0986-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656703PMC
November 2017

A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder.

Expert Rev Pharmacoecon Outcomes Res 2017 Jun 26;17(3):283-292. Epub 2016 Dec 26.

f Department of Medicine, Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1271325DOI Listing
June 2017

ADHD Symptoms and Quality of Life Across a 12-Month Period in Children With ADHD: A Longitudinal Study.

J Atten Disord 2017 May 1:1087054717707046. Epub 2017 May 1.

1 Murdoch Childrens Research Institute, Parkville, Australia.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1087054717707046
Publisher Site
http://dx.doi.org/10.1177/1087054717707046DOI Listing
May 2017

Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.

BMJ 2017 May 31;357:j2350. Epub 2017 May 31.

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450015PMC
http://dx.doi.org/10.1136/bmj.j2350DOI Listing
May 2017

Annual Research Review: Quality of life and childhood mental and behavioural disorders - a critical review of the research.

J Child Psychol Psychiatry 2017 Apr 6;58(4):439-469. Epub 2016 Oct 6.

Neuropsychiatry Unit, Department of Women's and Children's Health, Center of Neurodevelopmental Disorders (KIND), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpp.12645DOI Listing
April 2017

What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?

Atten Defic Hyperact Disord 2017 Mar;9(1):1-3

Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12402-017-0220-2
Publisher Site
http://dx.doi.org/10.1007/s12402-017-0220-2DOI Listing
March 2017

Prenatal Risk Factors and the Etiology of ADHD-Review of Existing Evidence.

Curr Psychiatry Rep 2017 Jan;19(1)

Murdoch Childrens Research Institute, Parkville, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11920-017-0753-2DOI Listing
January 2017

Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater.

Evid Based Ment Health 2016 11 6;19(4):97-99. Epub 2016 Oct 6.

Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://ebmh.bmj.com/lookup/doi/10.1136/eb-2016-102461
Publisher Site
http://dx.doi.org/10.1136/eb-2016-102461DOI Listing
November 2016

Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.

Lancet 2016 Aug 8;388(10047):881-90. Epub 2016 Jun 8.

Department of Neurology and Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Institute of Neuroscience and the Collaborative Innovation Center for Brain Science, Chongqing Medical University, Chongqing, China; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)30385-3DOI Listing
August 2016

Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities.

Asia Pac Psychiatry 2016 Jun 25;8(2):127-35. Epub 2015 Sep 25.

Department of Child and Adolescent Psychiatry, University of Dundee, Dundee, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/appy.12213DOI Listing
June 2016

BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents.

J Psychopharmacol 2016 05;30(5):416-21

University of Nottingham and Institute of Mental Health, Developmental Psychiatry, Queen's Medical Centre, Nottingham, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881116636107DOI Listing
May 2016

Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes.

Expert Rev Clin Pharmacol 2015 ;8(4):383-97

National Health Service Tayside, Child and Adolescent Mental Health Service, Dundee, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2015.1050379DOI Listing
March 2016

Ability and Disability in Autism Spectrum Disorder: A Systematic Literature Review Employing the International Classification of Functioning, Disability and Health-Children and Youth Version.

Autism Res 2015 Dec 28;8(6):782-94. Epub 2015 Mar 28.

From the Pediatric Neuropsychiatry Unit, Department of Women's and Children's Health, Center of Neurodevelopmental Disorders (KIND), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/aur.1485
Publisher Site
http://dx.doi.org/10.1002/aur.1485DOI Listing
December 2015

Towards an ICF core set for ADHD: a worldwide expert survey on ability and disability.

Eur Child Adolesc Psychiatry 2015 Dec 1;24(12):1509-21. Epub 2015 Oct 1.

Paediatric Neuropsychiatry Unit, Department of Women's and Children's Health, Center of Neurodevelopmental Disorders (KIND), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00787-015-0778
Web Search
http://link.springer.com/10.1007/s00787-015-0778-1
Publisher Site
http://dx.doi.org/10.1007/s00787-015-0778-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648970PMC
December 2015

Group cognitive-behavioural therapy may reduce symptoms and impairment in adolescents with attention-deficit/hyperactivity disorder.

Authors:
David Coghill

Evid Based Ment Health 2015 Nov 11;18(4):125. Epub 2015 Sep 11.

University of Dundee, Dundee, UK;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/eb-2015-102150DOI Listing
November 2015

Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway.

Child Adolesc Psychiatry Ment Health 2015 19;9:52. Epub 2015 Nov 19.

Division of Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY UK.

View Article

Download full-text PDF

Source
http://www.capmh.com/content/9/1/52
Publisher Site
http://dx.doi.org/10.1186/s13034-015-0083-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652349PMC
November 2015

Editorial: Painting by numbers: using modern approaches to analyse and visualise clinical and research data.

Authors:
David Coghill

J Child Psychol Psychiatry 2015 Oct;56(10):1035-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpp.12467DOI Listing
October 2015

Commentary: We've only just begun: unravelling the underlying genetics of neurodevelopmental disorders--a commentary on Kiser et al. (2015).

Authors:
David Coghill

J Child Psychol Psychiatry 2015 Mar;56(3):296-8

Division of Neuroscience, Medical Research Institute, University of Dundee, Dundee, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpp.12399DOI Listing
March 2015

Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.

J Psychopharmacol 2015 Jan 18;29(1):24-30. Epub 2014 Sep 18.

Division of Neuroscience, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881114548438DOI Listing
January 2015

Methylphenidate and the risk of trauma.

Pediatrics 2015 Jan 15;135(1):40-8. Epub 2014 Dec 15.

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2014-1738DOI Listing
January 2015

Prevalence and contributing factors to attention deficit hyperactivity disorder: a study of five- to fifteen-year-old children in Zhabei District, Shanghai.

Asia Pac Psychiatry 2014 Dec 2;6(4):397-404. Epub 2013 Dec 2.

Department of Medical Psychology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/appy.12114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288828PMC
December 2014

The use of stimulant medications for non-core aspects of ADHD and in other disorders.

Neuropharmacology 2014 Dec 18;87:161-72. Epub 2014 Jun 18.

Division of Neuroscience, University of Dundee, Dundee, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2014.06.014DOI Listing
December 2014

Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.

CNS Drugs 2014 Dec;28(12):1191-203

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, P.O. Box: 12 21 20, 68072, Mannheim, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-014-0193-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246127PMC
December 2014

The foundations of next generation attention-deficit/hyperactivity disorder neuropsychology: building on progress during the last 30 years.

J Child Psychol Psychiatry 2014 Dec;55(12):e1-5

Developmental Brain-Behaviour Laboratory, Psychology, Institute for Disorders of Impulse & Attention, University of Southampton, Southampton, UK; Department of Experimental Clinical & Health Psychology, Ghent University, Ghent, Belgium; Department of Child Psychiatry, University of Aarhus, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jcpp.12360
Publisher Site
http://dx.doi.org/10.1111/jcpp.12360DOI Listing
December 2014

Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.

CNS Drugs 2014 Nov;28(11):1059-69

Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, PO Box 12 21 20, 68072, Mannheim, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-014-0188-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221603PMC
November 2014

Editorial perspective: Laying the foundations for next generation models of ADHD neuropsychology.

J Child Psychol Psychiatry 2014 Nov;55(11):1215-7

Developmental Brain-Behaviour Laboratory, Psychology, Institute for Disorders of Impulse & Attention, University of Southampton, Southampton, UK; Department of Experimental Clinical & Health Psychology, Ghent University, Ghent, Belgium; Department of Child Psychiatry, University of Aarhus, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpp.12341DOI Listing
November 2014

Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.

Biol Psychiatry 2014 Oct 12;76(8):603-15. Epub 2013 Oct 12.

Department of Pediatric Science, University of Messina, Policlinico Universitario G. Martino, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2013.10.005DOI Listing
October 2014

Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification.

Hum Brain Mapp 2014 Oct 13;35(10):5179-89. Epub 2014 May 13.

Division of Neuroscience, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hbm.22542DOI Listing
October 2014

A systematic review of the safety of lisdexamfetamine dimesylate.

CNS Drugs 2014 Jun;28(6):497-511

Division of Neuroscience, University of Dundee, Dundee, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-014-0166-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057639PMC
June 2014

Brain imaging: closing the gap between basic research and clinical application is urgently needed.

Eur Child Adolesc Psychiatry 2013 Dec;22(12):715-7

Department of Cognitive Neuroscience, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-013-0493-8DOI Listing
December 2013

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.

Eur Neuropsychopharmacol 2013 Oct 15;23(10):1208-18. Epub 2013 Jan 15.

Division of Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2012.11.012DOI Listing
October 2013

Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.

CNS Drugs 2013 Oct;27(10):829-40

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, P.O. Box: 12 21 20, D-68072, Mannheim, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-013-0095-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784063PMC
October 2013

The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).

Child Adolesc Psychiatry Ment Health 2013 Oct 11;7(1):34. Epub 2013 Oct 11.

Primary Care and Public Health, School of Medicine, The Pharma Research Centre, Cardiff Medicentre, Cardiff University, Cardiff CF14 4UJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1753-2000-7-34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856565PMC
October 2013

Editorial: do clinical services need to take conduct disorder more seriously?

Authors:
David Coghill

J Child Psychol Psychiatry 2013 Sep;54(9):921-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpp.12135DOI Listing
September 2013

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

J Child Psychol Psychiatry 2013 Mar 7;54(3):227-46. Epub 2013 Jan 7.

Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, Child Study Center of the NYU Langone Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcpp.12036DOI Listing
March 2013

Occupational issues of adults with ADHD.

BMC Psychiatry 2013 Feb 17;13:59. Epub 2013 Feb 17.

South West Yorkshire NHS Partnership Foundation Trust Manygates Clinic, Portobello Road, WF1 5PN, Wakefield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-244X-13-59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599848PMC
February 2013

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.

Eur Child Adolesc Psychiatry 2012 Sep 5;21(9):477-92. Epub 2012 Jul 5.

Shire Pharmaceuticals, Wayne, PA 19087, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-012-0286-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777PMC
September 2012

Editorial: Getting the basics right in mental health assessments of children and young people.

Authors:
David Coghill

J Child Psychol Psychiatry 2012 Aug;53(8):815-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1469-7610.2012.02591.xDOI Listing
August 2012

Annual research review: categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders--implications of recent empirical study.

J Child Psychol Psychiatry 2012 May 31;53(5):469-89. Epub 2012 Jan 31.

Division of Medical Sciences, Centre for Neuroscience, University of Dundee, Dundee Institute for Disorder of Impulse and Attention, University of Southampton, Southampton, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1469-7610.2011.02511.x
Publisher Site
http://dx.doi.org/10.1111/j.1469-7610.2011.02511.xDOI Listing
May 2012

A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder.

J Child Psychol Psychiatry 2012 Feb 19;53(2):128-37. Epub 2011 Jul 19.

Department of Psychology, University of Strathclyde, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1469-7610.2011.02436.xDOI Listing
February 2012

What does it mean?; looking beyond group differences in clinical research.

Authors:
David Coghill

Eur Child Adolesc Psychiatry 2011 Dec;20(11-12):537-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-011-0222-0DOI Listing
December 2011

Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD.

BMC Psychiatry 2011 Nov 3;11:174. Epub 2011 Nov 3.

Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-244X-11-174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229466PMC
November 2011